Seroquel Sustained-Release Could Avert Sunset On Patent Exclusivity, AstraZeneca Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Company will file an NDA for the SR formulation of quetiapine for schizophrenia in July.